25 results
HIV Associated Infections Based on CD4 Count 

#Diagnosis #InfectiousDisease #CD4Count #HIV #AIDS #Opportunistic #Infections #OI #Table
Infections Based on CD4 ... #Diagnosis #InfectiousDisease ... CD4Count #HIV #AIDS #Opportunistic ... Infections #OI #Table ... #Prophylaxis #CD4
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... • Hepatitis A virus ... #Prophylaxis #Opportunistic ... Infections #OIs #HIVAIDS ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... • Hepatitis A virus ... #Prophylaxis #Opportunistic ... Infections #OIs #HIVAIDS ... IDSA #management #pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
causing COVID-19 ... ivermectin… #COVID19 ... Pandemic #Outbreak #InfectiousDiseases ... EmergencyMedicine #Pharmacology ... #Treatment #Virus
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
chronic hepatitis C virus ... DAAs #Antivirals #table ... #medications #infectiousdisease ... HepatitisC #Management #Pharmacology
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
HIV-Associated CNS Opportunistic ... : • Most CNS opportunistic ... • CNS opportunistic ... • JC-virus PCR ... #InfectiousDiseases
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Patients with CD4 ... Primary Prophylaxis: CD4 ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Persistence of clinically relevant viruses on dry inanimate surfaces

Most common viruses persist on surfaces for days
Polio virus Type ... Pseudorabies virus ... viruses #surfaces #infectiousdiseases ... #diagnosis #table ... contagiousness #COVID19
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
leishmaniasis and CD4 ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology